 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
OBJECTIVE: To describe a case of epididymo-orchitis that developed four years after treatment with intravesical bacillus Calmette-Guerin (BCG) and to review the incidence of this adverse effect. DATA SOURCES: Information about the patient was obtained from the medical chart. A MEDLINE search of English-language literature (from January 1976 to April 1999) was conducted. STUDY SELECTION: All case reports of BCG-related epididymo-orchitis were evaluated. Review articles describing complications of BCG therapy for bladder cancer and the prevention and treatment of these complications were reviewed. DATA EXTRACTION: Studies were evaluated for reports of BCG-related epididymo-orchitis and its treatment. DATA SYNTHESIS: Our case report is compared with others reported in the literature. The incidence of BCG-associated epididymoorchitis is rare. CONCLUSIONS: Epididymo-orchitis should be considered as a late complication of BCG therapy for bladder cancer. Proper patient selection may help decrease the risk of complications from BCG therapy.
This article has been cited by other articles:
|
|
 |
|
  R. Salvador, R. Vilana, X. Bargallo, X. Araque, and C. Nicolau Tuberculous Epididymo-orchitis After Intravesical BCG Therapy for Superficial Bladder Carcinoma: Sonographic Findings J. Ultrasound Med., May 1, 2007; 26(5): 671 - 674. [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. K. Chan and P. N. Schlegel Inflammatory Conditions of the Male Excurrent Ductal System. Part I. J Androl, July 1, 2002; 23(4): 453 - 460. [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
